SlideShare a Scribd company logo
Infections of the respiratory system
Overview
Haemophilus species
Staphylococcus species S. aureus
non-hemolytic streptococci
a-hemolytic streptococci S. pneumoniae
Diphtheroids
Gram positive bacteria
Microbiota of the upper respiratory system
The upper respiratory system is colonized by many
different microorganisms including
Lower respiratory tract
 Typically microorganisms are not present in the lower
respiratory system (axenic environment)
 Ciliary escalator
 Alveolar macrophages
 IgA
 Inflammation of the pharynx
 Caused by group A
streptococci (Streptococcus
pyogenes)
 Seasonal incidence (winter
and spring), spreads via
respiratory droplets, treatable
with antibacterial drugs
Streptococcal pharyngitis – strep throat
 Can be associated with scarlet fever (scarlatina), rash that spreads across
the body, the tongue becomes strawberry red
 Untreated streptococcal pharyngitis can involve rheumatic fever
(inflammation of heart valves and muscle) and acute glomerulonephritis
 Corynebacterium diphtheriae
 Diphteria toxin is an inhibitor
of protein synthesis
 Vaccination against diphtheria is
part of the DTaP protocol
 Localized infection presents as
severe pharyngitis with plaque-like
pseudomembrane in the throat
 C. diphtheriae can also cause
systemic infection due to toxemia,
affecting nerves, kidney, or heart
Diphtheria
Bacterial pneumonia
 One of the most serious lower respiratory tract infections
 Inflammation of the lungs in which bronchioles/alveoli become
filled with fluid. The lung’s gas exchange is impaired
 Signs/symptoms include fever, chest pain, cough with or
without production of sputum
 Nosocomial pneumonia acquired in a health care setting
 Staphylococcus aureus
 Gram negative pneumonia
Klebsiella pneumoniae
 Can cause tissue damage with
production of thick, bloody
sputum
Bacterial pneumonia
 Community-acquired pneumonia
Streptococcus pneumoniae
Staphylococcus aureus
Haemophilus influenzae
Mycoplasma pneumoniae
Legionella pneumophila
Chlamydia psittaci-ornithosis
Chlamydia pneumoniae
Mycoplasma pneumoniae
 Walking pneumonia (not severe enough to cause
hospitalization) – nonproductive cough
Bacterial pneumonia
Pneumococcal pneumonia
 Rusty colored sputum is
coughed-up, containing
neutrophils
 Fall/winter
 Children, elderly,
immunocompromised patients
 Treatment with antibiotics
 Vaccine that target several
strains of S. pneumoniae for
children and elderly
Bacterial pneumonia
Legionella pneumophila causes
legionellosis
 Dry nonproductive cough
 Decreases pulmonary
function - potentially fatal
pneumonia
 Transmitted through air
conditioning systems, water
pipes, …..
 Resistant to heat and
chlorination
 Person-to-person spread is
not known
Pleomorphic, Gram negative
Tuberculosis (TB)
 Caused by Mycobacterium tuberculosis, a problem for the immune
system because it resists phagocytosis
 Primary tuberculosis involves
the formation of nodules in the
lungs called tubercles
 Secondary or reactivated TB,
Mycobacterium spreads through
the lungs from tubercles (after
decades from primary TB)
 In disseminated TB, the pathogen spreads throughout the body,
affecting different organs
Tuberculosis (TB)
 Chest X rays can reveal the presence of tubercles in the lungs
Tuberculosis (TB)
 Acid-fast cells/cords in sputum
indicate active case of
tuberculosis
 Patient must be monitored to assure compliance with drug therapy
 Directly Observed Treatment Shortcourse (DOTS) used to
prevent spread of tuberculosis and MDR/XDR strains
 Immunization with M. bovis vaccine can induce immunity in
patients
Tuberculosis (TB)
 Tuberculin skin test
 Positive test
 Appearance of red
swelling at the test
site (24-72h)
 A positive test cannot distinguish between
 chronic carriers and patients with active disease, or
 people that have been exposed to Mycobacterium or
immunized but currently uninfected
Tuberculosis (TB)
About one-third of the world’s population is infected, deaths of 1-3
million people per year
Pertussis – whooping cough (DTaP)
 Bordetella pertussis (Gram
negative)
 Pertussis is highly contagious,
spread through respiratory
droplets
 Severe form in children
younger than five years old
Bordetella stops the ciliary escalator
 Characteristic signs of whooping cough occur during the paroxysmal
phase: persistent, severe coughing spells, leading to vomiting,
cyanosis, exhaustion
 DTaP vaccine (aP, acellular component) - immunity is not lifelong
Inhalation anthrax (zoonosis)
 Inhalation anthrax is a respiratory disease caused by inhalation
of spores of Bacillus anthracis
 B. anthracis resists phagocytosis
by alveolar macrophages
 Vegetative cells produce the
anthrax toxin, causing rapid
 Damage to the lungs
 Toxemia
 Bacillus can be seen in the sputum of patients
 Serological, DNA, biochemical tests confirm
the presence of B. anthracis
 Early treatment increases the survival rate of patients
 Antimicrobial drugs
 Drainage of fluid from around the lungs
 Anthrax vaccine available to
 Military personnel
 people who work with animals
 researchers
 health care professionals with anthrax patients
Inhalation anthrax (zoonosis)
 Potential weapon of bioterrorism
Systemic mycoses: diseases caused by fungi that spread
throughout the body
 Inhalation of
arthroconidia from soil
germinate in the alveoli
 Coccidioidomycosis is caused by Coccidioides immitis
 C. immitis is a dimorphic fungus
 Patients can experience mild
respiratory symptoms or
 More severe infections
involving coughing up blood
and pneumonia
 When it spreads from the lungs to the CNS can lead to meningitis
but it is fatal if untreated
Systemic mycoses: diseases caused by fungi that spread
throughout the body
Arthroconidia germinate in
the alveoli
 Diagnosis
 Identification of
spherules in clinical
specimens
 C. immitis spreads to
subcutaneous tissues
causing lesions
Painless lesions
 Treatment requires antifungal drugs which
may cause toxicity problems
Systemic mycoses: diseases caused by fungi that spread
throughout the body
The geographic distributions of three systemic fungal diseases
endemic to North America
 Dimorphic fungi
 Blastomycosis associated with Blastomyces dermatitidis
 Histoplasmosis caused by Histoplasma capsulatum

More Related Content

What's hot

Bacterial diseases
Bacterial diseasesBacterial diseases
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
Shabab Ali
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
hodmedicine
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
M.Arumuga Vignesh
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
Mahmood Khaleel
 
Anthrax
Anthrax Anthrax
Anthrax
arosababa
 
10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura
Shabab Ali
 
Austin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & TreatmentAustin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & Treatment
Austin Publishing Group
 
Bordetella
BordetellaBordetella
Bacterial infection
Bacterial infectionBacterial infection
Bacterial infection
Alaa Elnagar
 
Tuberculosis
Tuberculosis Tuberculosis
Clinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tbClinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tb
roshanjha8888
 
Mycobacterium Tuberculosis
Mycobacterium TuberculosisMycobacterium Tuberculosis
Mycobacterium Tuberculosis
Mohsin Javed
 
Modes of transmission
Modes of transmissionModes of transmission
Modes of transmission
Dr Shubhangi (Kshirsagar) Hedau
 
Mycobacterial diseases
Mycobacterial diseasesMycobacterial diseases
Mycobacterial diseases
Guvera Vasireddy
 
12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura
Shabab Ali
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
NoorFatima428
 
Bacterial diseases
Bacterial diseasesBacterial diseases
Bacterial diseases
Anulekshmi Rajkrishnan
 
Tb path & pathogenesis
Tb path & pathogenesis Tb path & pathogenesis
Tb path & pathogenesis
Dr.Manish Kumar
 
Selected human infectious diseases part 1
Selected human infectious diseases part 1Selected human infectious diseases part 1
Selected human infectious diseases part 1
Jason Sulit
 

What's hot (20)

Bacterial diseases
Bacterial diseasesBacterial diseases
Bacterial diseases
 
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
Anthrax
Anthrax Anthrax
Anthrax
 
10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura
 
Austin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & TreatmentAustin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & Treatment
 
Bordetella
BordetellaBordetella
Bordetella
 
Bacterial infection
Bacterial infectionBacterial infection
Bacterial infection
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Clinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tbClinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tb
 
Mycobacterium Tuberculosis
Mycobacterium TuberculosisMycobacterium Tuberculosis
Mycobacterium Tuberculosis
 
Modes of transmission
Modes of transmissionModes of transmission
Modes of transmission
 
Mycobacterial diseases
Mycobacterial diseasesMycobacterial diseases
Mycobacterial diseases
 
12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Bacterial diseases
Bacterial diseasesBacterial diseases
Bacterial diseases
 
Tb path & pathogenesis
Tb path & pathogenesis Tb path & pathogenesis
Tb path & pathogenesis
 
Selected human infectious diseases part 1
Selected human infectious diseases part 1Selected human infectious diseases part 1
Selected human infectious diseases part 1
 

Viewers also liked

Lecture 8, fall 2014
Lecture 8, fall 2014Lecture 8, fall 2014
Lecture 8, fall 2014
Shabab Ali
 
Lecture 9, fall 2014
Lecture 9, fall 2014Lecture 9, fall 2014
Lecture 9, fall 2014
Shabab Ali
 
Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014
Shabab Ali
 
Lecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfLecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdf
Shabab Ali
 
Lecture 7, fall 2014
Lecture 7, fall 2014Lecture 7, fall 2014
Lecture 7, fall 2014
Shabab Ali
 
Lecture 3, spring 2014
Lecture 3, spring 2014Lecture 3, spring 2014
Lecture 3, spring 2014
Shabab Ali
 
Lecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfLecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdf
Shabab Ali
 
Preanalytical variables in coagulation testing
Preanalytical variables in coagulation testingPreanalytical variables in coagulation testing
Preanalytical variables in coagulation testing
Shabab Ali
 
Lecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfLecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdf
Shabab Ali
 
Lecture 1, fall 2014
Lecture 1, fall 2014Lecture 1, fall 2014
Lecture 1, fall 2014
Shabab Ali
 
Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014
Shabab Ali
 
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
Shabab Ali
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
Shabab Ali
 
Lab parasites sections 1 xbc-!xcs
Lab parasites   sections 1 xbc-!xcsLab parasites   sections 1 xbc-!xcs
Lab parasites sections 1 xbc-!xcs
Shabab Ali
 
Colonial morphology
Colonial morphologyColonial morphology
Colonial morphology
Shabab Ali
 
Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)
Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)
Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)
Sergios Dimitriadis
 
Give peace a chance
Give peace a chanceGive peace a chance
Give peace a chance
elharala
 
Ulrich schmutz garden organic research on drought and drylands
Ulrich schmutz garden organic research on drought and drylandsUlrich schmutz garden organic research on drought and drylands
Ulrich schmutz garden organic research on drought and drylandsJoy Elliott
 
Give peace a chance
Give peace a chanceGive peace a chance
Give peace a chanceelharala
 

Viewers also liked (20)

Lecture 8, fall 2014
Lecture 8, fall 2014Lecture 8, fall 2014
Lecture 8, fall 2014
 
Lecture 9, fall 2014
Lecture 9, fall 2014Lecture 9, fall 2014
Lecture 9, fall 2014
 
Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014
 
Lecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfLecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdf
 
Lecture 7, fall 2014
Lecture 7, fall 2014Lecture 7, fall 2014
Lecture 7, fall 2014
 
Lecture 3, spring 2014
Lecture 3, spring 2014Lecture 3, spring 2014
Lecture 3, spring 2014
 
Lecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfLecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdf
 
Preanalytical variables in coagulation testing
Preanalytical variables in coagulation testingPreanalytical variables in coagulation testing
Preanalytical variables in coagulation testing
 
Lecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfLecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdf
 
Lecture 1, fall 2014
Lecture 1, fall 2014Lecture 1, fall 2014
Lecture 1, fall 2014
 
Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014
 
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
 
Lab parasites sections 1 xbc-!xcs
Lab parasites   sections 1 xbc-!xcsLab parasites   sections 1 xbc-!xcs
Lab parasites sections 1 xbc-!xcs
 
Colonial morphology
Colonial morphologyColonial morphology
Colonial morphology
 
Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)
Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)
Περιμένοντας ή διαμορφώνοντας το μέλλον; (in Greek)
 
Give peace a chance
Give peace a chanceGive peace a chance
Give peace a chance
 
Ulrich schmutz garden organic research on drought and drylands
Ulrich schmutz garden organic research on drought and drylandsUlrich schmutz garden organic research on drought and drylands
Ulrich schmutz garden organic research on drought and drylands
 
Give peace a chance
Give peace a chanceGive peace a chance
Give peace a chance
 
Sunu (1)
Sunu (1)Sunu (1)
Sunu (1)
 

Similar to 11 bio265 disease of respiratory system instructor dr di bonaventura

2.respiratory infections
2.respiratory infections2.respiratory infections
2.respiratory infectionsRavi Teja
 
New PPT Presentation.pptx
New PPT Presentation.pptxNew PPT Presentation.pptx
New PPT Presentation.pptx
ssuseref3feb
 
141363130-respiratory-tract-infection.ppt
141363130-respiratory-tract-infection.ppt141363130-respiratory-tract-infection.ppt
141363130-respiratory-tract-infection.ppt
BayanAlsaadi
 
youfgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghg
youfgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghgyoufgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghg
youfgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghg
khaalidmohamed6
 
respiratory tract infections
respiratory tract infectionsrespiratory tract infections
respiratory tract infections
pentakota sandhya
 
Infectious Diseases Affecting the Respiratory System
Infectious Diseases Affecting the Respiratory SystemInfectious Diseases Affecting the Respiratory System
Infectious Diseases Affecting the Respiratory System
Cheng Mendoza
 
Lecture 14 disorders of the respiratory system- Pathology
Lecture 14 disorders of the respiratory system- Pathology Lecture 14 disorders of the respiratory system- Pathology
Lecture 14 disorders of the respiratory system- Pathology
Areej Abu Hanieh
 
Pneumonia
PneumoniaPneumonia
Pneumonia
Pediatrics
 
ENT and eye infections Notes.pdf
ENT and eye infections Notes.pdfENT and eye infections Notes.pdf
ENT and eye infections Notes.pdf
BayanAlsaadi
 
Respiratory Diseases
Respiratory DiseasesRespiratory Diseases
Respiratory Diseasesshas595
 
Bronchitis
BronchitisBronchitis
Bronchitis
Sanket Patel
 
Pulmonary tb lec
Pulmonary tb lec Pulmonary tb lec
Pulmonary tb lec
DOCTOR WHO
 
air borne disease by ujwal virkhare
air borne disease by ujwal virkhareair borne disease by ujwal virkhare
air borne disease by ujwal virkhare
UjwalVirkhare1
 
03 URTI.pptx
03 URTI.pptx03 URTI.pptx
03 URTI.pptx
WoldeyohannesTesfa
 
Pulmonary tb lec & practical
Pulmonary tb lec & practical Pulmonary tb lec & practical
Pulmonary tb lec & practical
imrana tanvir
 
Aerobiology
Aerobiology Aerobiology
Aerobiology
shamroz7700
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
HariomSuman
 

Similar to 11 bio265 disease of respiratory system instructor dr di bonaventura (20)

RTIs
RTIsRTIs
RTIs
 
Chapter24
Chapter24Chapter24
Chapter24
 
2.respiratory infections
2.respiratory infections2.respiratory infections
2.respiratory infections
 
New PPT Presentation.pptx
New PPT Presentation.pptxNew PPT Presentation.pptx
New PPT Presentation.pptx
 
141363130-respiratory-tract-infection.ppt
141363130-respiratory-tract-infection.ppt141363130-respiratory-tract-infection.ppt
141363130-respiratory-tract-infection.ppt
 
youfgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghg
youfgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghgyoufgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghg
youfgfgfhhggnvggghghghzsdsdfdrgvgf ftytgfyffhthgygygtghghghghghghg
 
respiratory tract infections
respiratory tract infectionsrespiratory tract infections
respiratory tract infections
 
Infectious Diseases Affecting the Respiratory System
Infectious Diseases Affecting the Respiratory SystemInfectious Diseases Affecting the Respiratory System
Infectious Diseases Affecting the Respiratory System
 
Lecture 14 disorders of the respiratory system- Pathology
Lecture 14 disorders of the respiratory system- Pathology Lecture 14 disorders of the respiratory system- Pathology
Lecture 14 disorders of the respiratory system- Pathology
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
ENT and eye infections Notes.pdf
ENT and eye infections Notes.pdfENT and eye infections Notes.pdf
ENT and eye infections Notes.pdf
 
Respiratory Diseases
Respiratory DiseasesRespiratory Diseases
Respiratory Diseases
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
Pulmonary tb lec
Pulmonary tb lec Pulmonary tb lec
Pulmonary tb lec
 
air borne disease by ujwal virkhare
air borne disease by ujwal virkhareair borne disease by ujwal virkhare
air borne disease by ujwal virkhare
 
03 URTI.pptx
03 URTI.pptx03 URTI.pptx
03 URTI.pptx
 
Pulmonary tb lec & practical
Pulmonary tb lec & practical Pulmonary tb lec & practical
Pulmonary tb lec & practical
 
Aerobiology
Aerobiology Aerobiology
Aerobiology
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
 

More from Shabab Ali

Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiology
Shabab Ali
 
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6  1 xbc and 1xcs _dr di bonaventuraBio265 lab 6  1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Shabab Ali
 
7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura
Shabab Ali
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy
5 bio265 antimicrobial agents instructor dr di bonaventura   copy5 bio265 antimicrobial agents instructor dr di bonaventura   copy
5 bio265 antimicrobial agents instructor dr di bonaventura copy
Shabab Ali
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
Shabab Ali
 
4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura
Shabab Ali
 
3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura
Shabab Ali
 
2 bio265 prokaryotes vs eukaryotes_dr di bonaventura
2 bio265 prokaryotes vs eukaryotes_dr di bonaventura2 bio265 prokaryotes vs eukaryotes_dr di bonaventura
2 bio265 prokaryotes vs eukaryotes_dr di bonaventura
Shabab Ali
 
1 bio265 introduction to microbiology_dr di bonaventura_instructor
1 bio265  introduction to microbiology_dr di bonaventura_instructor1 bio265  introduction to microbiology_dr di bonaventura_instructor
1 bio265 introduction to microbiology_dr di bonaventura_instructor
Shabab Ali
 
Ch23 (4)
Ch23 (4)Ch23 (4)
Ch23 (4)
Shabab Ali
 
Ch17 transplant immunology (2)
Ch17 transplant immunology (2)Ch17 transplant immunology (2)
Ch17 transplant immunology (2)
Shabab Ali
 

More from Shabab Ali (11)

Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiology
 
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6  1 xbc and 1xcs _dr di bonaventuraBio265 lab 6  1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
 
7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy
5 bio265 antimicrobial agents instructor dr di bonaventura   copy5 bio265 antimicrobial agents instructor dr di bonaventura   copy
5 bio265 antimicrobial agents instructor dr di bonaventura copy
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
 
4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura
 
3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura
 
2 bio265 prokaryotes vs eukaryotes_dr di bonaventura
2 bio265 prokaryotes vs eukaryotes_dr di bonaventura2 bio265 prokaryotes vs eukaryotes_dr di bonaventura
2 bio265 prokaryotes vs eukaryotes_dr di bonaventura
 
1 bio265 introduction to microbiology_dr di bonaventura_instructor
1 bio265  introduction to microbiology_dr di bonaventura_instructor1 bio265  introduction to microbiology_dr di bonaventura_instructor
1 bio265 introduction to microbiology_dr di bonaventura_instructor
 
Ch23 (4)
Ch23 (4)Ch23 (4)
Ch23 (4)
 
Ch17 transplant immunology (2)
Ch17 transplant immunology (2)Ch17 transplant immunology (2)
Ch17 transplant immunology (2)
 

Recently uploaded

Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Mudde & Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...
Mudde &  Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...Mudde &  Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...
Mudde & Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...
frank0071
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills MN
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
yqqaatn0
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
SSR02
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
Wasswaderrick3
 
Anemia_ types_clinical significance.pptx
Anemia_ types_clinical significance.pptxAnemia_ types_clinical significance.pptx
Anemia_ types_clinical significance.pptx
muralinath2
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
kejapriya1
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
RASHMI M G
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 

Recently uploaded (20)

Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Mudde & Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...
Mudde &  Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...Mudde &  Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...
Mudde & Rovira Kaltwasser. - Populism in Europe and the Americas - Threat Or...
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
 
Anemia_ types_clinical significance.pptx
Anemia_ types_clinical significance.pptxAnemia_ types_clinical significance.pptx
Anemia_ types_clinical significance.pptx
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 

11 bio265 disease of respiratory system instructor dr di bonaventura

  • 1. Infections of the respiratory system Overview
  • 2. Haemophilus species Staphylococcus species S. aureus non-hemolytic streptococci a-hemolytic streptococci S. pneumoniae Diphtheroids Gram positive bacteria Microbiota of the upper respiratory system The upper respiratory system is colonized by many different microorganisms including
  • 3. Lower respiratory tract  Typically microorganisms are not present in the lower respiratory system (axenic environment)  Ciliary escalator  Alveolar macrophages  IgA
  • 4.  Inflammation of the pharynx  Caused by group A streptococci (Streptococcus pyogenes)  Seasonal incidence (winter and spring), spreads via respiratory droplets, treatable with antibacterial drugs Streptococcal pharyngitis – strep throat  Can be associated with scarlet fever (scarlatina), rash that spreads across the body, the tongue becomes strawberry red  Untreated streptococcal pharyngitis can involve rheumatic fever (inflammation of heart valves and muscle) and acute glomerulonephritis
  • 5.  Corynebacterium diphtheriae  Diphteria toxin is an inhibitor of protein synthesis  Vaccination against diphtheria is part of the DTaP protocol  Localized infection presents as severe pharyngitis with plaque-like pseudomembrane in the throat  C. diphtheriae can also cause systemic infection due to toxemia, affecting nerves, kidney, or heart Diphtheria
  • 6. Bacterial pneumonia  One of the most serious lower respiratory tract infections  Inflammation of the lungs in which bronchioles/alveoli become filled with fluid. The lung’s gas exchange is impaired  Signs/symptoms include fever, chest pain, cough with or without production of sputum  Nosocomial pneumonia acquired in a health care setting  Staphylococcus aureus  Gram negative pneumonia Klebsiella pneumoniae  Can cause tissue damage with production of thick, bloody sputum
  • 7. Bacterial pneumonia  Community-acquired pneumonia Streptococcus pneumoniae Staphylococcus aureus Haemophilus influenzae Mycoplasma pneumoniae Legionella pneumophila Chlamydia psittaci-ornithosis Chlamydia pneumoniae Mycoplasma pneumoniae  Walking pneumonia (not severe enough to cause hospitalization) – nonproductive cough
  • 8. Bacterial pneumonia Pneumococcal pneumonia  Rusty colored sputum is coughed-up, containing neutrophils  Fall/winter  Children, elderly, immunocompromised patients  Treatment with antibiotics  Vaccine that target several strains of S. pneumoniae for children and elderly
  • 9. Bacterial pneumonia Legionella pneumophila causes legionellosis  Dry nonproductive cough  Decreases pulmonary function - potentially fatal pneumonia  Transmitted through air conditioning systems, water pipes, …..  Resistant to heat and chlorination  Person-to-person spread is not known Pleomorphic, Gram negative
  • 10. Tuberculosis (TB)  Caused by Mycobacterium tuberculosis, a problem for the immune system because it resists phagocytosis  Primary tuberculosis involves the formation of nodules in the lungs called tubercles  Secondary or reactivated TB, Mycobacterium spreads through the lungs from tubercles (after decades from primary TB)  In disseminated TB, the pathogen spreads throughout the body, affecting different organs
  • 11. Tuberculosis (TB)  Chest X rays can reveal the presence of tubercles in the lungs
  • 12. Tuberculosis (TB)  Acid-fast cells/cords in sputum indicate active case of tuberculosis  Patient must be monitored to assure compliance with drug therapy  Directly Observed Treatment Shortcourse (DOTS) used to prevent spread of tuberculosis and MDR/XDR strains  Immunization with M. bovis vaccine can induce immunity in patients
  • 13. Tuberculosis (TB)  Tuberculin skin test  Positive test  Appearance of red swelling at the test site (24-72h)  A positive test cannot distinguish between  chronic carriers and patients with active disease, or  people that have been exposed to Mycobacterium or immunized but currently uninfected
  • 14. Tuberculosis (TB) About one-third of the world’s population is infected, deaths of 1-3 million people per year
  • 15. Pertussis – whooping cough (DTaP)  Bordetella pertussis (Gram negative)  Pertussis is highly contagious, spread through respiratory droplets  Severe form in children younger than five years old Bordetella stops the ciliary escalator  Characteristic signs of whooping cough occur during the paroxysmal phase: persistent, severe coughing spells, leading to vomiting, cyanosis, exhaustion  DTaP vaccine (aP, acellular component) - immunity is not lifelong
  • 16. Inhalation anthrax (zoonosis)  Inhalation anthrax is a respiratory disease caused by inhalation of spores of Bacillus anthracis  B. anthracis resists phagocytosis by alveolar macrophages  Vegetative cells produce the anthrax toxin, causing rapid  Damage to the lungs  Toxemia  Bacillus can be seen in the sputum of patients  Serological, DNA, biochemical tests confirm the presence of B. anthracis
  • 17.  Early treatment increases the survival rate of patients  Antimicrobial drugs  Drainage of fluid from around the lungs  Anthrax vaccine available to  Military personnel  people who work with animals  researchers  health care professionals with anthrax patients Inhalation anthrax (zoonosis)  Potential weapon of bioterrorism
  • 18. Systemic mycoses: diseases caused by fungi that spread throughout the body  Inhalation of arthroconidia from soil germinate in the alveoli  Coccidioidomycosis is caused by Coccidioides immitis  C. immitis is a dimorphic fungus
  • 19.  Patients can experience mild respiratory symptoms or  More severe infections involving coughing up blood and pneumonia  When it spreads from the lungs to the CNS can lead to meningitis but it is fatal if untreated Systemic mycoses: diseases caused by fungi that spread throughout the body Arthroconidia germinate in the alveoli
  • 20.  Diagnosis  Identification of spherules in clinical specimens  C. immitis spreads to subcutaneous tissues causing lesions Painless lesions  Treatment requires antifungal drugs which may cause toxicity problems Systemic mycoses: diseases caused by fungi that spread throughout the body
  • 21. The geographic distributions of three systemic fungal diseases endemic to North America  Dimorphic fungi  Blastomycosis associated with Blastomyces dermatitidis  Histoplasmosis caused by Histoplasma capsulatum